dihexa hgf c met potentiator Frontiers HGF/c-MET pathway in cancer: from
HGF c MET pathway in cancer: from molecular characterization to clinical evidence Oncogene Positive Modulation of HGF MET by Fosgonimeton. Hypothesized fast onset Download Scientific Diagram Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect DIHEXA
Pay in 4 interest-free payments of $5.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


